Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017524612> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2017524612 endingPage "A45" @default.
- W2017524612 startingPage "A45" @default.
- W2017524612 abstract "<h3>Background</h3> Low vitamin D status is associated with an increased risk of autoimmune diseases, including rheumatoid arthritis. Thus, understanding how vitamin D modifies immune reactions holds therapeutic potential. The authors have shown that 1,25(OH)<sub>2</sub>D<sub>3</sub>, acts directly upon human CD4 T cells, suppressing inflammatory cytokines (interleukin (IL)-17, IL-21, IFNγ and IL-22) while enhancing regulatory-markers (CTLA-4, CD25, FoxP3 and IL-10). However, the short half life of 1,25(OH)<sub>2</sub>D<sub>3</sub> and its low serum level imply that local conversion of 25(OH)D<sub>3</sub>, the major circulating form of vitamin D, by 1α-hydroxylase (CYP27B1), is necessary for immune regulation in vivo. Thus, the authors have studied the effect of 25(OH)D<sub>3</sub> upon T cell responses. In view of the critical role of CTLA-4 in immune-regulation and its strong sensitivity to 1,25(OH)<sub>2</sub>D<sub>3</sub>, the authors have also investigated CTLA-4 function in vitamin D-modified immune responses. <h3>Methods</h3> CD4<sup>+</sup>CD25<sup>−</sup> T cells were purified from human peripheral blood (PB) and stimulated with LPS-matured allogenic dendritic cells (DCs) plus anti-CD3 or with anti-CD3/CD28 beads in the presence and absence of 25(OH)D<sub>3</sub>. FoxP3, CTLA-4 and cytokines were measured by flow cytometry and CYP27B1 by qPCR. In function assays, CTLA-4 was blocked with anti-CTLA-4 and T cell division monitored. DC expression of CD80 and CD86 was assessed by FACS. PB and synovial fluid (SF) mononuclear cells, from patients with synovitis, were stimulated with antiCD3 in the presence and absence of 1,25(OH)<sub>2</sub>D<sub>3</sub> and cytokines examined by FACS. <h3>Results</h3> Stimulation of T cells by DCs in the presence of 25(OH)D<sub>3</sub> led to strong suppression of IL-17 and IFNγ but upregulation of CTLA-4 and CTLA-4<sup>+</sup>FoxP3<sup>+</sup> frequencies. By contrast, in the absence of DCs, 25(OH)D<sub>3</sub> caused modest CTLA-4 induction and IFNγ suppression (p<0.05 for all). These differences corresponded with CYP27B1 levels, as maturation induced much higher CYP27B1 in DCs than arose in T cells (p<0.05). CTLA-4 blockade overcame 1,25(OH)<sub>2</sub>D<sub>3</sub>-mediated suppression of T cell division in DC stimulations and prevented downregulation of co-stimulatory CD80 and CD86 on DCs. PB T cells from synovitis patients responded normally to 1,25(OH)<sub>2</sub>D<sub>3</sub> with suppressed IL-17 and IFNγ (p<0.0001). 1,25(OH)<sub>2</sub>D<sub>3</sub> also reduced IL-17 (p<0.05) but not IFNγ in SF T cells. <h3>Conclusions</h3> The authors have shown that DCs can efficiently convert 25(OH)D<sub>3</sub> to drive 1,25(OH)<sub>2</sub>D<sub>3</sub>-modified T cell responses and that upregulation of CTLA-4 is mechanistically important in immune suppression by vitamin D. Thus, 25(OH)D<sub>3</sub> supplement could be useful in the treatment of conditions such as RA. This is supported by the authors9 finding that T cells from synovitis patients can respond to 1,25(OH)<sub>2</sub>D<sub>3</sub>." @default.
- W2017524612 created "2016-06-24" @default.
- W2017524612 creator A5047260745 @default.
- W2017524612 creator A5051103543 @default.
- W2017524612 creator A5065756541 @default.
- W2017524612 creator A5070677442 @default.
- W2017524612 date "2011-02-22" @default.
- W2017524612 modified "2023-09-24" @default.
- W2017524612 title "25-hydroxyvitamin D3 conversion by dendritic cells and T cells drives 1,25-dihydroxyvitamin D3 mediated anti-inflammatory CD4+ T cell responses" @default.
- W2017524612 doi "https://doi.org/10.1136/ard.2010.148981.8" @default.
- W2017524612 hasPublicationYear "2011" @default.
- W2017524612 type Work @default.
- W2017524612 sameAs 2017524612 @default.
- W2017524612 citedByCount "4" @default.
- W2017524612 countsByYear W20175246122013 @default.
- W2017524612 countsByYear W20175246122017 @default.
- W2017524612 countsByYear W20175246122019 @default.
- W2017524612 countsByYear W20175246122022 @default.
- W2017524612 crossrefType "journal-article" @default.
- W2017524612 hasAuthorship W2017524612A5047260745 @default.
- W2017524612 hasAuthorship W2017524612A5051103543 @default.
- W2017524612 hasAuthorship W2017524612A5065756541 @default.
- W2017524612 hasAuthorship W2017524612A5070677442 @default.
- W2017524612 hasBestOaLocation W20175246121 @default.
- W2017524612 hasConcept C124490489 @default.
- W2017524612 hasConcept C126322002 @default.
- W2017524612 hasConcept C134018914 @default.
- W2017524612 hasConcept C148125776 @default.
- W2017524612 hasConcept C187316574 @default.
- W2017524612 hasConcept C203014093 @default.
- W2017524612 hasConcept C21705690 @default.
- W2017524612 hasConcept C2776079296 @default.
- W2017524612 hasConcept C2776090121 @default.
- W2017524612 hasConcept C2778296632 @default.
- W2017524612 hasConcept C2779727006 @default.
- W2017524612 hasConcept C71924100 @default.
- W2017524612 hasConcept C79484868 @default.
- W2017524612 hasConcept C8891405 @default.
- W2017524612 hasConceptScore W2017524612C124490489 @default.
- W2017524612 hasConceptScore W2017524612C126322002 @default.
- W2017524612 hasConceptScore W2017524612C134018914 @default.
- W2017524612 hasConceptScore W2017524612C148125776 @default.
- W2017524612 hasConceptScore W2017524612C187316574 @default.
- W2017524612 hasConceptScore W2017524612C203014093 @default.
- W2017524612 hasConceptScore W2017524612C21705690 @default.
- W2017524612 hasConceptScore W2017524612C2776079296 @default.
- W2017524612 hasConceptScore W2017524612C2776090121 @default.
- W2017524612 hasConceptScore W2017524612C2778296632 @default.
- W2017524612 hasConceptScore W2017524612C2779727006 @default.
- W2017524612 hasConceptScore W2017524612C71924100 @default.
- W2017524612 hasConceptScore W2017524612C79484868 @default.
- W2017524612 hasConceptScore W2017524612C8891405 @default.
- W2017524612 hasIssue "Suppl 2" @default.
- W2017524612 hasLocation W20175246121 @default.
- W2017524612 hasOpenAccess W2017524612 @default.
- W2017524612 hasPrimaryLocation W20175246121 @default.
- W2017524612 hasRelatedWork W134794155 @default.
- W2017524612 hasRelatedWork W1991065145 @default.
- W2017524612 hasRelatedWork W2019022043 @default.
- W2017524612 hasRelatedWork W2047109864 @default.
- W2017524612 hasRelatedWork W2105170173 @default.
- W2017524612 hasRelatedWork W2124199305 @default.
- W2017524612 hasRelatedWork W2162979395 @default.
- W2017524612 hasRelatedWork W2613921741 @default.
- W2017524612 hasRelatedWork W47284607 @default.
- W2017524612 hasRelatedWork W128433041 @default.
- W2017524612 hasVolume "70" @default.
- W2017524612 isParatext "false" @default.
- W2017524612 isRetracted "false" @default.
- W2017524612 magId "2017524612" @default.
- W2017524612 workType "article" @default.